| "COVID-19 Vaccines” for Children in the UK: A Tale of Establishment Corruption |
| A case of fatal multi-organ inflammation following COVID-19 vaccination |
| A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products |
| A Systematic Review of Autopsy Findings in Deaths after COVID-19 Vaccination |
| A Systematic Review of COVID-19 Vaccine-Induced Takotsubo Cardiomyopathy: A 2023 Update |
| Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome |
| Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia |
| Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study |
| Advisory Committee on Vaccines (Australia) - Meeting 22 - Minutes on Item 2.1 - BNT162b2 [mRNA] COVID-19 vaccine |
| Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines |
| An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination |
| Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries |
| Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches |
| Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? |
| Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data |
| Assessment of cardiac adverse events following COVID‑19 vaccination by speckle tracking echocardiography |
| Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients |
| Association of SARS-CoV-2 immunoserology and vaccination status with myocardial infarction severity and outcome |
| Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues |
| Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis |
| Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose |
| Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination |
| Briefing Document: Vaccines and Related Biological Products Advisory Committee Meeting 2021-10-26 |
| Cardiac Adverse Reactions With COVID-19 Vaccinations |
| Cardiac and Neurological Complications Post COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series |
| Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study |
| Cardiac Multiple Micro-Scars: An Autopsy Study |
| Cardiac side effects of RNA-based SARS-CoV-2 vaccines: Hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure |
| Cardiopulmonary Arrest After COVID-19 Vaccination: A Case Report |
| Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination |
| Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents |
| Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2 |
| Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings |
| Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis |
| Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality? |
| Clinical Considerations: Myocarditis and Pericarditis after Receipt of COVID-19 Vaccines Among Adolescents and Young Adults |
| Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study |
| Clinically suspected lethal viral myocarditis combined with encephalitis: a COVID-19 vaccine complication |
| Compilation: Peer Reviewed Medical Papers of COVID Vaccine Injuries |
| Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures |
| COVID Vaccine Autopsy Reports: Shocking Impact Revealed |
| COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2 |
| COVID-19 mRNA Vaccine Induced Pericarditis With Large Pericardial Effusion Followed by New-Onset Arrhythmia |
| COVID-19 Vaccination and Cardiovascular Events: A Systematic Review and Bayesian Multivariate Meta-Analysis of Preventive Benefits and Risks |
| COVID-19 Vaccination-Associated Myocarditis: A Literature Review |
| COVID-19 Vaccination-Induced Cardiomyopathy Requiring Permanent Left Ventricular Assist Device |
| COVID-19 vaccination-related myocarditis: a Korean nationwide study |
| COVID-19 Vaccination-Related Myocarditis: What We Learned From Our Experience and What We Need to Do in The Future |
| COVID-19 Vaccine Safety Technical (VaST) Work Group |
| COVID-19 vaccine safety update: Primary series in young children and booster doses in older children and adults |
